20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Dapagliflozin Tetraacetate: The Chemical Foundation for Novel Diabetes Therapies

The development of effective therapies for diabetes is a continuous endeavor, and at the core of this progress lies advanced chemical synthesis. NINGBO INNO PHARMCHEM CO.,LTD. recognizes the pivotal role of Dapagliflozin Tetraacetate (CAS 461432-25-7) as a foundational chemical intermediate in this field. This compound is instrumental in the production of Dapagliflozin, a critical medication that has transformed the management of type 2 diabetes.

Dapagliflozin Tetraacetate, with its precise molecular structure and high purity (typically Dapagliflozin Tetraacetate purity 99%), is essential for the complex organic synthesis required to create the Dapagliflozin API. The compound’s specific chemical properties, derived from its molecular formula C29H33ClO10, make it an ideal building block for constructing the SGLT2 inhibitor molecule. This attention to detail in chemical composition ensures the safety and efficacy of the final pharmaceutical product.

For researchers and manufacturers in the pharmaceutical sector, securing a reliable supply of key intermediates is paramount. NINGBO INNO PHARMCHEM CO.,LTD. is a dedicated Dapagliflozin Intermediate supplier, committed to providing high-quality Dapagliflozin Tetraacetate to support the ongoing development of diabetes treatments. By offering this compound, we empower our clients to push the boundaries of therapeutic innovation and improve patient outcomes.

The importance of sourcing high-quality intermediates cannot be overstated. When companies choose to buy Dapagliflozin Tetraacetate from NINGBO INNO PHARMCHEM CO.,LTD., they are investing in a partnership that values precision, reliability, and scientific advancement. Our commitment extends beyond mere supply; we aim to be a collaborative force in bringing novel and effective diabetes therapies to market.

NINGBO INNO PHARMCHEM CO.,LTD. is proud to contribute to the chemical foundation of novel diabetes therapies by providing essential intermediates like Dapagliflozin Tetraacetate. We remain committed to supporting the pharmaceutical industry’s vital work in combating diabetes and improving global health.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Global Access to Dapagliflozin Tetraacetate (CAS 461432-25-7): Empowering Pharmaceutical Innovation

Next: The Role of Rebeprazole Sodium in Modern Gastrointestinal Treatments

All Rights Reserved